Related Experiment Video
Updated: Jan 21, 2026
Use of Galleria mellonella as a Model Organism to Study Legionella pneumophila Infection
Published on: November 22, 2013
[Legionella and Legionellosis]
Martin Kolditz1, Christian Lück2
1Abteilung für Pneumologie, Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden.
Abstract:
Diagnosed and reported Legionella pneumonias are slightly increasing during recent years. This might at least partially be due to more frequently used diagnostic tests.In severe pneumonia, nucleic acid amplification based methods should supplement the L. pneumophila serogroup-1 urinary antigen test because of their improved spectrum and sensitivity.Recent in vitro data suggest enhanced efficacy of levofloxacin when compared to macrolides. This complements recent clinical cohort data. Thus levofloxacin (750-1000 mg/d) is regarded the treatment of choice for confirmed legionellosis. Second line options are azithromycin or moxifloxacin. Treatment duration of 7 days should be sufficient in most cases.Development of resistance is rare and no routine resistance testing is necessary.
Insights
Legionella pneumonia diagnoses are increasing, possibly due to better testing. Levofloxacin is the preferred treatment for Legionnaires
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Diagnosed Legionella pneumonias show a slight increase in recent years.
- Increased diagnostic testing may contribute to the observed rise in reported cases.
- Legionella is a significant cause of community-acquired and hospital-acquired pneumonia.
Purpose of the Study:
- To review current diagnostic and treatment strategies for Legionella pneumonia.
- To evaluate the role of nucleic acid amplification methods and antibiotic efficacy.
- To provide updated treatment guidelines for confirmed legionellosis.
Main Methods:
- Review of recent in vitro data on antibiotic efficacy.
- Analysis of clinical cohort data for treatment outcomes.
- Evaluation of diagnostic test performance, including urinary antigen tests and nucleic acid amplification methods.
Main Results:
- Nucleic acid amplification tests offer improved spectrum and sensitivity over urinary antigen tests for severe pneumonia.
- Levofloxacin demonstrates enhanced efficacy compared to macrolides in vitro and in clinical cohorts.
- A 7-day treatment duration is generally sufficient for most legionellosis cases.
Conclusions:
- Levofloxacin (750-1000 mg/d) is the recommended treatment of choice for confirmed Legionnaires' disease.
- Azithromycin or moxifloxacin serve as second-line treatment options.
- Routine resistance testing for Legionella is not necessary due to rare development of resistance.
More Related Videos
08:34Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
Published on: February 22, 2017
09:12Applying Live Cell Imaging and Cryo-Electron Tomography to Resolve Spatiotemporal Features of the Legionella pneumophila Dot/Icm Secretion System
Published on: March 10, 2020